Papageorgiou Sotirios G, Sachanas Sotirios, Pangalis Gerassimos A, Tsopra Olga, Levidou Georgia, Foukas Periklis, Rondogianni Phoivi, Sotiropoulos Vasileios, Ioannidou Helen-Dikaia, Gassiamis Argyris, Iliakis Theodoros, Korkolopoulou Penelope, Angelopoulou Maria K, Pappa Vasiliki, Konstantopoulos Konstantinos, Vassilakopoulos Theodoros P
Second Department of Internal Medicine, Propaedeutic, Hematology Unit, Attikon General Hospital, University of Athens Medical School, Athens, Greece.
Department of Haematology, Athens Medical Center, Psychiko Branch, Athens, Greece.
Anticancer Res. 2014 Nov;34(11):6717-23.
Gastric involvement is unusual in primary mediastinal large B-cell lymphoma (PMLBCL), which has not yet been adequately studied. The aim of this retrospective study was to investigate the frequency of gastric involvement in 204 consecutive patients with PMLBCL that presented at 23 hospitals in Greece. Two out of 204 patients (1.0%) had gastric involvement at presentation. The first patient had symptomatic gastric disease manifested as upper gastrointestinal (GI) hemorrhage, which was the presenting symptom (first case reported in the literature). The second patient underwent positron emission tomography/computed tomography (PET/CT) at baseline staging which revealed abnormal gastric uptake. Histological examination revealed discordant lymphomatous involvement (MALT lymphoma, in a 33-year old female). The estimated frequency of gastric involvement by conventional staging was 1/204 (0.49%), but no cases were identified among asymptomatic patients. Among asymptomatic patients who underwent PET/CT at baseline staging, the PET/CT-based frequency of gastric involvement was 7.1%, but lymphomatous gastric involvement was discordant. Finally, the frequency of gastric involvement in primary progressive or relapsed disease was 2.2%. Our study shows that gastric involvement is uncommon but can be seen in different clinical settings at presentation or at progression/relapse of PMLBCL. PET/CT-based staging may provide more accurate information regarding the true incidence of sub-clinical gastric involvement in this entity, but histological confirmation is essential in order to confirm the diagnosis.
胃受累在原发性纵隔大B细胞淋巴瘤(PMLBCL)中并不常见,对此尚未进行充分研究。这项回顾性研究的目的是调查希腊23家医院连续收治的204例PMLBCL患者胃受累的频率。204例患者中有2例(1.0%)在初诊时出现胃受累。第一例患者有症状性胃部疾病,表现为上消化道(GI)出血,这是首发症状(文献报道的首例)。第二例患者在基线分期时接受了正电子发射断层扫描/计算机断层扫描(PET/CT),显示胃部摄取异常。组织学检查显示为不一致的淋巴瘤累及(黏膜相关淋巴组织淋巴瘤,见于一名33岁女性)。根据传统分期估计胃受累的频率为1/204(0.49%),但无症状患者中未发现病例。在基线分期时接受PET/CT的无症状患者中,基于PET/CT的胃受累频率为7.1%,但淋巴瘤性胃受累不一致。最后,原发性进展期或复发期疾病中胃受累的频率为2.2%。我们的研究表明,胃受累并不常见,但在PMLBCL的初诊、进展期或复发期的不同临床情况下均可出现。基于PET/CT的分期可能会提供有关该实体亚临床胃受累真实发生率的更准确信息,但组织学确诊对于确诊至关重要。